Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use
Conclusions
The intergenic region of CACNA2D3 and WNT5A was revealed as a novel locus for asthma exacerbations despite ICS treatment in European populations. Genes associated were related to trichostatin A, suggesting that this drug could regulate the molecular mechanisms involved in treatment response.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Hernandez-Pacheco, N., Vijverberg, S. J., Herrera-Luis, E., Li, J., Sio, Y. Y., Granell, R., Corrales, A., Maroteau, C., Lethem, R., Perez-Garcia, J., Farzan, N., Repnik, K., Gorenjak, M., Soares, P., Karimi, L., Schieck, M., Perez-Mendez, L., Berce, V., Tags: Genetics, Asthma and allergy Original Articles: Asthma and genetics Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | Corticosteroid Therapy | Genetics | Men | Respiratory Medicine | Study